A new project under way at the Mount Sinai Health System aims to analyze and expand the role of the nation’s emergency medical services (EMS) to serve as a vital link in a highly coordinated system focused on the acute medical needs of the community.
The project, titled “Promoting Innovations in Emergency Medical Services,” is a collaborative effort between Mount Sinai and the UC San Diego Health System. Backed by a $225,000 grant from the National Highway Traffic Safety Administration, and the U.S. Departments of Homeland Security and Health and Human Services, the project seeks to eliminate the regulatory, financial, technological, and training barriers that have stood in the way of a meaningful overhaul of the nation’s emergency medical services. Read more
More than 1,000 participants received free screenings for blood pressure, cholesterol, triglycerides, body mass index, and peripheral vascular disease at heart-health fairs sponsored by the Mount Sinai Health System on Friday, February 6, National Go Red for Women Day. Read more
The Mount Sinai Health System has entered into an agreement with Empire BlueCross BlueShield that is designed to enhance quality of care and help individuals maintain healthy habits, all while reducing the cost of care. Empire is the largest health insurer in New York State.
Under the innovative agreement, which became effective January 1, 2015, Mount Sinai will manage all aspects of care for Empire’s 48,000 commercial and Medicare members who are attributed to the Health System. This includes coordinating all medical treatment, closely monitoring the patient between physician visits, and ensuring that appropriate follow-up care is received. Patients with chronic or complex conditions will receive individualized care plans tailored to their specific needs. Read more
Mount Sinai Beth Israel Security Guard Will Parker, also a talented singer, actor, and composer, gave an informal vocal performance on Monday, February 2, at Mount Sinai Beth Israel Phillips Ambulatory Care Center. He sang a variety of tunes, including songs from Broadway musicals, jazz, spirituals, and a tribute to Nat King Cole. Joanne Loewy, DA, LCAT, MT-BC, Director, The Louis Armstrong Center for Music & Medicine, Mount Sinai Beth Israel, accompanied Mr. Parker on piano; and Andrew Rossetti, MMT, MT-BC, LCAT, Coordinator of Music Therapy, Radiation Oncology, Mount Sinai Beth Israel, backed him up on guitar. The event kicked off “Celebrating Black History Month” and was co-sponsored by Mount Sinai Beth Israel’s Diversity Council and The Louis Armstrong Center for Music & Medicine.
Kristjan T. Ragnarsson, MD, the Dr. Lucy G. Moses Professor and Chair of the Department of Rehabilitation Medicine for the Mount Sinai Health System, was recently honored by the American Academy of Physical Medicine and Rehabilitation with its 2014 Frank H. Krusen, MD, Lifetime Achievement Award, its highest honor. The Academy saluted Dr. Ragnarsson’s longtime commitment to patient care, research, education, and advocacy. The award was established in 1972 for Dr. Krusen, a founding father of the Academy and early developer of the Physical Medicine and Rehabilitation specialty. Read more
The Mount Sinai Health System received the first Outstanding Employer Award from STRIVE (Support Training Results In Valuable Employees) on Tuesday, January 20, at the New York Yale Club, for its exceptional commitment to training and hiring graduates from the STRIVE program. The organization presents the award to employers who help individuals with high barriers to employment—such as recovering addicts, public assistance recipients, and the working poor—develop marketable skills and gain employment in living-wage jobs. Read more
Seminal research led by James Ferrara, MD, DSc, Ward-Coleman Chair in Cancer Medicine, has produced a promising approach to treating patients with graft-versus-host disease (GVHD)—a sometimes fatal complication of bone marrow transplantation in which the donor’s immune cells attack the recipient’s body. Bone marrow transplants are often used to treat patients with leukemia, lymphoma, and other blood diseases. Read more